Cardiovascular Complications of Hematopoietic Stem Cell Transplantation

10Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

Abstract

Survivors of hematopoietic stem cell transplant (HSCT) are at significant risk for cardiac disease and cardiac complications. While there may be cardiac complications during the acute period of HSCT, long-term survivors remain at risk for cardiovascular disease at a rate at least fourfold higher than the general population. Aggressive screening for cardiac risk factors such as diabetes, hypertension, and arrhythmias is warranted pretransplant. For those with risk factors, particularly a history of cardiovascular disease or atrial fibrillation, cardiology consultation is warranted in the pretransplantation period. Aggressive screening for cardiac risk factors such as diabetes, hypertension, and hyperlipidemia is warranted in HSCT survivors as well; early and aggressive treatment of left ventricular dysfunction is warranted. Collaboration between hematology/oncology and cardiology through a cardio-oncology clinic is an optimal way to help manage these patients.

Cite

CITATION STYLE

APA

Blaes, A., Konety, S., & Hurley, P. (2016, April 1). Cardiovascular Complications of Hematopoietic Stem Cell Transplantation. Current Treatment Options in Cardiovascular Medicine. Springer Healthcare. https://doi.org/10.1007/s11936-016-0447-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free